ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in ImageneBio, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +8 vs. Q3 2025
- Shares held
- 4.77M
- +21.0K (+0.4%) vs. Q3 2025
- Total value
- $32.9M
- −$5.43M (−14.2%) vs. Q3 2025
- New holders
- 14
- 12 more added
- Sold out
- 6
- 5 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Blue Owl Capital Holdings LP | 823,785 | $5.68M | 1.75% | +282,861+52.3% | Added |
| BVF Inc | 802,102 | $5.53M | 0.19% | 00.0% | Unchanged |
| Cable Car Capital LLC | 643,933 | $4.44M | 0.28% | +643,933 | New |
| Omega Fund Management, LLC | 455,361 | $3.14M | 1.10% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 378,556 | $2.61M | 0.05% | 00.0% | Unchanged |
| RTW Investments, LP | 334,445 | $2.31M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 238,000 | $1.64M | 0.00% | +4,642+2.0% | Added |
| BML Capital Management, LLC | 177,026 | $1.22M | 1.08% | −5,483−3.0% | Reduced |
| BlackRock, Inc. | 131,587 | $908.0K | 0.00% | +79,476+152.5% | Added |
| Monashee Investment Management LLC | 91,621 | $632.2K | 0.36% | +91,621 | New |
| Citadel Advisors LLC | 86,478 | $596.7K | 0.00% | −35,769−29.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 66,666 | $460.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 66,096 | $456.1K | 0.00% | +28,718+76.8% | Added |
| Geode Capital Management, LLC | 54,146 | $373.6K | 0.00% | +6,458+13.5% | Added |
| NEA Management Company, LLC | 50,005 | $345.0K | 0.02% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 48,237 | $332.8K | 0.00% | +24,067+99.6% | Added |
| DRW Securities, LLC | 43,768 | $302.0K | 0.02% | +43,768 | New |
| HSBC Holdings PLC | 34,228 | $233.1K | 0.00% | +34,228 | New |
| Sofinnova Investments, Inc. | 31,884 | $220.0K | 0.01% | 00.0% | Unchanged |
| Nano Cap New Millennium Growth Fund L P | 26,500 | $182.8K | 0.16% | +26,500 | New |
| Shay Capital LLC | 23,216 | $160.2K | 0.03% | +23,216 | New |
| Aldebaran Capital, LLC | 19,070 | $131.6K | 0.12% | −492−2.5% | Reduced |
| Jacobs Levy Equity Management, Inc | 18,727 | $129.2K | 0.00% | +1,019+5.8% | Added |
| Rangeley Capital, LLC | 18,244 | $125.9K | 0.11% | +3,244+21.6% | Added |
| Jane Street Group, LLC | 14,896 | $102.8K | 0.00% | +14,896 | New |
| Prelude Capital Management, LLC | 13,495 | $93.1K | 0.01% | +13,495 | New |
| T3 Companies, LLC | 13,200 | $91.1K | 0.12% | +13,200 | New |
| XTX Topco Ltd | 12,177 | $84.0K | 0.00% | −32,774−72.9% | Reduced |
| Millennium Management LLC | 11,454 | $79.0K | 0.00% | +11,454 | New |
| Goldman Sachs Group Inc | 10,950 | $75.6K | 0.00% | +10,950 | New |
| Barclays PLC | 10,797 | $74.5K | 0.00% | +6,810+170.8% | Added |
| Morgan Stanley | 10,771 | $74.3K | 0.00% | +9,485+737.6% | Added |
| UBS Group AG | 4,961 | $34.2K | 0.00% | +191+4.0% | Added |
| Bank of America Corp | 2,597 | $17.9K | 0.00% | +2,571+9,888.5% | Added |
| Royal Bank of Canada | 1,000 | $7.00K | 0.00% | +1,000 | New |
| GWM Advisors LLC | 491 | $3.39K | 0.00% | −12,469−96.2% | Reduced |
| Fortitude Family Office, LLC | 400 | $2.76K | 0.00% | +400 | New |
| JPMorgan Chase & Co | 70 | $483 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 41 | $283 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 24 | $166 | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 57 | $0 | 0.00% | +57 | New |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −878,516−100.0% | Sold out |
| Atlas Venture Life Science Advisors, LLC | 0 | $0 | 0.00% | −377,814−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −12,774−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −877−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |